Individual Brokerage -5489 - New Portfolio

Alexander Valiyaveedan

Individual Brokerage -5489
Individual Investor
Ranked #493,045 out of 748,626 TipRanks' Investors
Success Rate
41%
45 out of 110
profitable transactions
Average Return
-8.78%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 2.72%
6-Month Return▲ 15.73%
12-Month Return-
YTD Return▲ 4.56%
Total Return▼ 7.16%

Best Trade

Opened at
Closed at-
Gain▲ 352.78%

Bio

Performance

24.77%0-24.77%
▲ 5.14%
▲ 4.57%
▲ 7.53%
Dec 2023
▼ 1.87%
▲ 1.59%
▼ 9.21%
Jan 2024
▲ 14.08%
▲ 5.22%
▲ 9.57%
Feb 2024
▲ 5.05%
▲ 3.27%
▲ 7.81%
Mar 2024
▼ 12.40%
▼ 4.03%
▼ 2.01%
Apr 2024
▲ 11.46%
▲ 5.06%
▲ 10.97%
May 2024
▼ 2.25%
▲ 3.53%
▼ 13.20%
Jun 2024
▲ 24.77%
▼ 1.07%
▲ 3.28%
Jul 2024
TipRanks AverageS&P 500Investor Portfolio
▲ 5.14%▲ 4.57%▲ 7.53%
▼ 1.87%▲ 1.59%▼ 9.21%
▲ 14.08%▲ 5.22%▲ 9.57%
▲ 5.05%▲ 3.27%▲ 7.81%
▼ 12.40%▼ 4.03%▼ 2.01%
▲ 11.46%▲ 5.06%▲ 10.97%
▼ 2.25%▲ 3.53%▼ 13.20%
▲ 24.77%▼ 1.07%▲ 3.28%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Xtreme One Entertainment
0.03%
▲ 13.05%
3
Buy
May 10, 2024
Fuelcell Energy
2.19%
▼ 39.60%
2
Buy
May 10, 2024
Corus Entertainment
0.4%
▼ 83.99%
2
Buy
May 10, 2024
Kezar Life Sciences
1.51%
▼ 17.32%
2
Buy
May 10, 2024
CBD Life Sciences
0.01%
0.00%
3
Close
Apr 26, 2024
Bioline RX Ltd Sponsored ADR
12.23%
▼ 9.48%
4
Buy
Apr 24, 2024
B2Gold
6.58%
▲ 2.83%
2
Buy
Apr 22, 2024
Applied Digital Corporation
0.92%
▲ 12.31%
2
Buy
Apr 05, 2024
22nd Century
0.02%
▼ 78.30%
3
Buy
Apr 03, 2024
Ikena Oncology
0.35%
▲ 20.00%
1
Buy
Mar 26, 2024
CymaBay Therapeutics
▲ 96.61%
3
Close
Mar 25, 2024
BlackSky Technology
2.4%
▼ 14.62%
1
Buy
Mar 14, 2024
Canoo
0.2%
▼ 71.24%
3
Sell
Mar 07, 2024
Palatin Technologies
0.87%
▼ 9.05%
1
Buy
Mar 04, 2024
Sayona Mining
0.47%
▼ 51.28%
2
Buy
Feb 23, 2024
Sify Technologies
0.05%
▼ 72.01%
2
Buy
Feb 21, 2024
Aurora Cannabis
1.48%
▲ 3.11%
3
Sell
Feb 21, 2024
Exxon Mobil
0.02%
▲ 12.51%
1
Buy
Feb 21, 2024
SemiLEDs
0.31%
▼ 1.33%
1
Buy
Feb 21, 2024
Outlook Therapeutics
0.88%
▼ 0.71%
1
Buy
Feb 21, 2024